Depakote Linked to Increased Risk of Death for Patients with Poststroke Epilepsy: Study
Depakote use is associated with a 40% increased risk of death among poststroke patients who develop epilepsy, according to the findings of a new study.
Depakote use is associated with a 40% increased risk of death among poststroke patients who develop epilepsy, according to the findings of a new study.
The FDA is warning the side effects of Lamictal and potentially other antiseizure medications could increase the risk of heart rhythm problems in patients with heart disease.
A new study links the use of Tegretol and Lamictal to an increased risk of skin cancer.
A teenager prescribed Lamictal off-label suffered Stevens-Johnson Syndrome and was hospitalized for two weeks due to the drug's side effects.
A number of drugs, including Abilify, Lipitor and Zoloft, were linked to several uncommon, potentially deadly drug side effects in 2017, according to a new report.
The FDA warns that Lamictal side effects may cause potentially deadly immune system reactions and has added new label warnings to the drug.
A new study warns that exposure to Depakote in the womb could lead to poorer school performance for children later in life.
Preterm birth, low birth weight and unusually small heads should be added to the list of birth defect concerns linked to Depakote and other epilepsy drugs, researchers warn.
A new study's findings suggest that all antiseizure drugs, not just Depakote, could put children at risk of developmental delays when it is taken by pregnant women.
Additional research has been published that links potential side effects of Depakote to cognitive developmental delays among children who were exposed to the anti-epilepsy drug during pregnancy.